Additionally, the muramyl dipeptide from bacterial cell wall was a beneficial postbiotic which could mitigate obesity-induced insulin resistance by targeting nucleotide-binding oligomerization domain-containing protein 2 (NOD2) and interferon regulatory factor 4 (IRF4) [86]. The gene discussed is NOD2; the disease is Insulin resistance.